Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study

Abstract BACKGROUND The impact of cerebral amyloid pathology on cognitive and functional decline may differ with age. Evidence linking brain amyloidopathy to physical decline remains limited and inconsistent. This study investigated the association between brain amyloid status and cognitive and physical decline in (pre)frail older adults with cognitive impairment. METHODS This longitudinal analysis used data from the CogFrail study. Brain amyloid pathology was assessed using amyloid-positron emission tomography (visual reading). Linear mixed-effects models examined differences over a two-year follow-up between amyloid-positive and amyloid-negative participants in cognitive, functional, and physical trajectories. Cognitive and functional outcomes included the Mini-Mental State Examination, the Clinical Dementia Rating–Sum of Boxes, the Activities of Daily Living Index, and a neuropsychological battery, while the physical domain was assessed using handgrip strength, chair rise time, gait speed, and the Short Physical Performance Battery. RESULTS Among 199 participants (mean age 82.3 ± 4.8 years; 65.3% women), 108(54.3%) were amyloid-positive. Amyloid-positive participants experienced greater decline in the Clinical Dementia Rating–Sum of Boxes (β = 0.30, 95% CI 0.10–0.49; p = 0.003, log-transformed) and the Mini-Mental State Examination (β = –1.62, 95% CI –2.74 to –0.49; p = 0.005). No significant longitudinal differences were observed between groups in the Activities of Daily Living Index, neuropsychological outcomes, or physical performance measures. CONCLUSION Amyloid pathology assessment may help differentiate cognitive trajectories in cognitively impaired (pre)frail older adults. Greater cognitive decline in amyloid-positive participants was not associated with greater loss of independence or additional physical decline over time. TRIAL REGISTRATION NCT03129269

Authors

Institutions

Publication Details

Journal
The Journals of Gerontology Series A
Published
2026-11-14
DOI
https://doi.org/10.1093/gerona/glag259
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study

Gaëlle Soriano, Davide Angioni, Federico Bellelli, Sandrine Andrieu et al.
The Journals of Gerontology Series A
Dementia and Cognitive Impairment Research
article

Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study

Gaëlle Soriano, Davide Angioni, Federico Bellelli, Sandrine Andrieu, Christelle Cantet, Pierre Payoux, Julien Delrieu, Sandrine Sourdet, Bruno Vellas
article en

Abstract

Abstract BACKGROUND The impact of cerebral amyloid pathology on cognitive and functional decline may differ with age. Evidence linking brain amyloidopathy to physical decline remains limited and inconsistent. This study investigated the association between brain amyloid status and cognitive and physical decline in (pre)frail older adults with cognitive impairment. METHODS This longitudinal analysis used data from the CogFrail study. Brain amyloid pathology was assessed using amyloid-positron emission tomography (visual reading). Linear mixed-effects models examined differences over a two-year follow-up between amyloid-positive and amyloid-negative participants in cognitive, functional, and physical trajectories. Cognitive and functional outcomes included the Mini-Mental State Examination, the Clinical Dementia Rating–Sum of Boxes, the Activities of Daily Living Index, and a neuropsychological battery, while the physical domain was assessed using handgrip strength, chair rise time, gait speed, and the Short Physical Performance Battery. RESULTS Among 199 participants (mean age 82.3 ± 4.8 years; 65.3% women), 108(54.3%) were amyloid-positive. Amyloid-positive participants experienced greater decline in the Clinical Dementia Rating–Sum of Boxes (β = 0.30, 95% CI 0.10–0.49; p = 0.003, log-transformed) and the Mini-Mental State Examination (β = –1.62, 95% CI –2.74 to –0.49; p = 0.005). No significant longitudinal differences were observed between groups in the Activities of Daily Living Index, neuropsychological outcomes, or physical performance measures. CONCLUSION Amyloid pathology assessment may help differentiate cognitive trajectories in cognitively impaired (pre)frail older adults. Greater cognitive decline in amyloid-positive participants was not associated with greater loss of independence or additional physical decline over time. TRIAL REGISTRATION NCT03129269

The Journals of Gerontology Series A
Université Toulouse III - Paul Sabatier (FR), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Centre de recherche en Epidémiologie et Santé des Populations (FR), Université de Toulouse (FR), Toulouse NeuroImaging Center (FR)
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon